Flex's Post-Earnings Slump Reinforces Overvaluation Concerns

What happened

Flex Ltd. shares fell roughly 7% after the company reported second-quarter fiscal 2027 results on October 28, triggering fresh scrutiny of its valuation. The decline aligns with the DeepValue master report's 'POTENTIAL SELL' stance, which flagged that the stock traded about 74% above an FCF-based DCF estimate of $36.64 amid thin net margins and flat revenues. While Flex's scale, diversified end-markets, and improving free cash flow are real strengths, the market appears to be repricing the risk that recent margin gains may not be durable in a competitive EMS landscape. The latest earnings report likely offered little to justify the prior premium multiple, especially given lingering geopolitical risks and working-capital intensity. Consequently, the post-earnings drop is better viewed as a partial normalization toward intrinsic value rather than a compelling entry point.

Implication

The post-earnings decline reduces but does not eliminate the valuation gap, with the stock likely still priced for optimistic assumptions on margin sustainability and revenue growth. Flex's thin net margins (around 3%) and history of working-capital swings mean earnings could disappoint if demand softens or costs rise, amplifying downside risk from geopolitical disruptions. Until management demonstrates sustained FCF above $1 billion annually and stable or growing revenues, the risk/reward remains unfavorable relative to the DCF-based intrinsic value of roughly $36-$40 per share. A move closer to that range, or evidence of structurally higher margins, would be needed to shift the stance to neutral or constructive. For now, the thesis remains a 'POTENTIAL SELL,' and any rebound toward the mid-$60s should be used to reduce exposure.

Thesis delta

The latest earnings-driven selloff modestly reduces the prior overvaluation but does not alter the bearish thesis; the stock is still trading at a premium to conservative intrinsic value. The decline from the mid-$60s to around $59 likely reflects the market's recognition that thin margins and cyclicality limit upside. The thesis shifts only slightly from 'clearly overvalued' to 'still overvalued with slightly better risk/reward,' but not enough to change the 'POTENTIAL SELL' judgment.